Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata [Phase 3]

View source ↗

Summary

AbbVie is conducting a Phase 3 study in Japan to evaluate the safety and effectiveness of upadacitinib tablets for alopecia areata in adults and adolescents. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Alopecia Areata | Phase 3 | Status: RECRUITING